Bajaj HealthCare Intrinsic Value
Bajaj HealthCare (BAJAJHCARE) median intrinsic value is ₹195.18 from 8 valuation models (range ₹97–₹647), vs current price ₹323.35 — -39.6% downside (Trading Above Calculated Value), margin of safety -65.7%. Read BAJAJHCARE dividend history for the complete payout history and dividend yield track record.
BAJAJHCARE Valuation Methods Summary — DCF, Graham Number & P/E
Bajaj HealthCare intrinsic value across 8 models vs current price ₹323.35 — upside/downside and value range per method. Analyse BAJAJHCARE shareholding pattern to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹118.80 | ₹95.04 - ₹142.56 | -63.3% | EPS: ₹5.40, Sector P/E: 22x |
| Book Value Method | asset | ₹627.06 | ₹564.35 - ₹689.77 | +93.9% | Book Value/Share: ₹313.53, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹646.70 | ₹582.03 - ₹711.37 | +100.0% | Revenue/Share: ₹373.53, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹458.82 | ₹412.94 - ₹504.70 | +41.9% | EBITDA: ₹78.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹129.34 | ₹103.47 - ₹155.21 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹97.01 | ₹87.31 - ₹106.71 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹97.01 | ₹87.31 - ₹106.71 | -70.0% | Revenue Growth: -0.5%, Adj P/E: 15.0x |
| Graham Defensive Method | conservative | ₹195.18 | ₹175.66 - ₹214.70 | -39.6% | EPS: ₹5.40, BVPS: ₹313.53 |
BAJAJHCARE Intrinsic Value vs Market Price — All Valuation Models
Bajaj HealthCare fair value range ₹97–₹647 vs current market price ₹323.35 across 8 valuation models. For current market price and key ratios, visit BAJAJHCARE share price screener.
BAJAJHCARE Intrinsic Value Analysis — Undervalued or Overvalued?
Bajaj HealthCare median intrinsic value ₹195.18, current price ₹323.35 — Trading Above Calculated Value by 39.6%, margin of safety -65.7%.
What is the intrinsic value of BAJAJHCARE?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Bajaj HealthCare (BAJAJHCARE) is ₹195.18 (median value). With the current market price of ₹323.35, this represents a -39.6% variance from our estimated fair value.
The valuation range spans from ₹97.01 to ₹646.70, indicating ₹97.01 - ₹646.70.
Is BAJAJHCARE undervalued or overvalued?
Based on our multi-method analysis, Bajaj HealthCare (BAJAJHCARE) appears to be trading above calculated value by approximately 39.6%.
BAJAJHCARE Financial Health — Key Ratios vs Industry Benchmarks
Bajaj HealthCare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 9.81 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 3.4% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 11.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.69x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
BAJAJHCARE Cash Flow Quality — Operating & Free Cash Flow
Bajaj HealthCare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹22 Cr | ₹15 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹92 Cr | ₹87 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-22 Cr | ₹-69 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹1 Cr | ₹-37 Cr | Positive Operating Cash Flow | 6/10 |
| March 2021 | ₹44 Cr | ₹-11 Cr | Positive Operating Cash Flow | 6/10 |